Download presentation
Presentation is loading. Please wait.
1
PROVISIONAL PROGRAM, PGDIS 2018: DAY ONE
Time Type Title 8:45-9:00 Welcome 9:00-9:30 Plenary Lecture The Evolution of PGT-A 9:30-10:00 Session 1: PGT PGT-A “in house”, is it safe and cost effective? 10:00-10:30 Session 1: PGT PGT-A as QC for IVF methods (this could be the same as aneuploidy rates vary by center) 10:30-11:00 Differences in amplification methods for PGT 11:00-11:30 Coffee Break 11:30-12:00 Session 2: PGT-M PG-M for de novo mutations 12:00-12:30 Insights on PGT from analysis of databases (SART, ESHRE, etc) 12:30-13:00 Session 2: PGT-SR PGD for Translocations and use of PGT-A 13:00-13:30 Session 2: PGT-A Aneuploidy rates in fertile patients undergoing PGT by map + PGD-A 13:30-14:30 Break Lunch and POSTER SESSION 14:30-16:00 Session 3: Abstracts 15 min per each abstract x 6 16:00-16:30 16:30-17:00 Session 4: Debate Debate on mosaics: to transfer or not to transfer 17:00-17:30 Endometrial Receptivity, what time is ideal time to transfer? 11/9/2018
2
PROVISIONAL PROGRAM, PGDIS 2018: DAY TWO
Time Type Title 8:00-8:15 Summary highlights from day one 8:15-8:45 Plenary lecture Origins of meiotic aneuploidy and post mitotic aneuploidy? 8:45-9:15 Session 5: Mosaicism Impact of Mosaicism on outcomes 9:15-9:45 Session 5: Mosaicism Improvement and standardization of biopsy procedures 9:45-10:15 Session 5: Mosaicism Rates of aneuploidy and Mosaicism differ between clinics 10:15-10:45 How to counsel around Mosaicism 10:45-11:15 Coffee Break 11:15-13:00 Session 6: Abstracts 15 min per each abstract x 6 13:00-14:00 BREAK Lunch and POSTER SESSION 14:00-15:30 Session 7: Regional Block 15:30-16:00 16:00-16:30 Session 8: Panels Genetic Panels for ovarian, breast and endometrial cancers 16:30-17:00 Genetic Panels for Infertility 17:00-17:30 TBD 11/9/2018
3
PROVISIONAL PROGRAM, PGDIS 2018: DAY THREE
Time Type Title 8:00-8:15 Summary highlights from day two 8:15-8:45 Plenary lecture 3 person babies 8:45-9:15 Session 9: Emerging Mitochondria: How do they impact embryo viability? 9:15-9:45 Emerging technologies - such as CRISPR 9:45-10:15 Non invasive PGD-A 10:15-10:45 Luteal support protocols and embryo chromosome abnormalities 10:45-11:15 Coffee Break 11:15-12:00 Session 10: Abstracts 15 min per each abstract x 6 12:00-13:00 Session 7: Regional Block 13:00-14:00 BREAK Lunch and POSTER SESSION 14:00-15:30 Late Breaking Session 30 minutes x 3 14:00-14:30 TBD based on submission 14:30-15:00 15:00-15:30 15:30-16:00 Closing remarks 11/9/2018
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.